13-May-2024
No headlines found.
Healthcare Realty Trust Reports Results for the First Quarter
Globe Newswire (Tue, 7-May 6:45 AM ET)
Healthcare Realty Trust Announces Strategic Joint Venture With KKR
Globe Newswire (Mon, 6-May 6:45 AM ET)
Healthcare Realty Trust Announces Quarterly Dividend
Globe Newswire (Tue, 30-Apr 4:03 PM ET)
Healthcare Realty Trust Announces First Quarter Earnings Release Date and Conference Call
Globe Newswire (Wed, 17-Apr 4:01 PM ET)
Healthcare Realty Trust Announces Planned Retirement of Two Directors and 2024 Nominees
Globe Newswire (Mon, 4-Mar 6:45 AM ET)
Healthcare Realty Trust Reports Results for the Fourth Quarter
Globe Newswire (Fri, 16-Feb 6:45 AM ET)
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company considers merger and acquisition investment as a component of its operational growth strategy. It works with developers that have strong ties to a local health system and physicians. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.
Healthcare Realty Trust trades on the NYSE stock market under the symbol HR.
As of May 13, 2024, HR stock price climbed to $16.01 with 5,158,320 million shares trading.
HR has a beta of 1.14, meaning it tends to be more sensitive to market movements. HR has a correlation of 0.22 to the broad based SPY ETF.
HR has a market cap of $6.06 billion. This is considered a Mid Cap stock.
Last quarter Healthcare Realty Trust reported $327 million in Revenue and $.39 earnings per share. This fell short of revenue expectation by $-85,000 and exceeded earnings estimates by $.01.
In the last 3 years, HR stock traded as high as $33.77 and as low as $12.77.
The top ETF exchange traded funds that HR belongs to (by Net Assets): VNQ, IJH, VTI, VB, VXF.
HR stock has underperformed the market in the last year with a return of -11.4%, while SPY returned +28.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HR shares. However, HR has outperformed the market in the last 3 month and 2 week periods, returning +9.3% and +14.5%, while SPY returned +5.8% and +2.1%, respectively. This indicates HR has been having a stronger performance recently.
HR support price is $15.12 and resistance is $15.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HR stock will trade within this expected range on the day.